Bifido, the first listed company in the microbiome field, announced on the 13th that a patent has been granted for a composition developed with its proprietary probiotics that can improve, prevent, ...

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus ...

Bifido (238200) has delivered a -10% change over the past year, with a 52-week range between 2,460 and 4,390. What Is the Average Daily Trading Volume of Bifido (238200)? The average daily trading ...

Amicogen, a KOSDAQ-listed company, has been confirmed to have borrowed 10 billion KRW from its subsidiary Bifido, which has experienced an embezzlement incident and defaulted on convertible bonds (CB) ...

Review the current valuation for Bifido Co Ltd Ordinary Shares (238200:XKRX) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.

Find the latest BIFIDO Co., Ltd. (238200.KQ) stock quote, history, news and other vital information to help you with your stock trading and investing.

Visit a quote page and your recently viewed tickers will be displayed here.